VANGUARD GROUP INC - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 47 filers reported holding ENTRADA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$16,097,127
+5.3%
1,129,623
+4.7%
0.00%
Q1 2024$15,288,126
-4.9%
1,078,908
+1.3%
0.00%
Q4 2023$16,073,355
-0.3%
1,065,166
+4.4%
0.00%
Q3 2023$16,121,009
+5.5%
1,020,317
+1.0%
0.00%
Q2 2023$15,287,599
+13.5%
1,009,749
+8.7%
0.00%
Q1 2023$13,465,642
+8.2%
928,665
+0.9%
0.00%
Q4 2022$12,441,821
-9.3%
920,253
+5.8%
0.00%
Q3 2022$13,714,000
+47.7%
870,147
+14.1%
0.00%
Q2 2022$9,285,000
+129.8%
762,364
+77.1%
0.00%
Q1 2022$4,041,000
-44.4%
430,404
+1.3%
0.00%
Q4 2021$7,274,000424,9520.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,425,784$66,785,08132.82%
5AM Venture Management, LLC 4,408,379$66,522,43917.65%
72 Investment Holdings, LLC 172,600$2,604,53411.56%
StepStone Group LP 761,277$11,487,6702.07%
TCG Crossover Management, LLC 584,955$8,826,9710.98%
Baker Brothers Advisors 4,865,819$73,425,2090.84%
Redmile Group, LLC 1,283,735$19,371,5610.69%
Nan Fung Group Holdings Ltd 49,082$740,6470.46%
Advantage Alpha Capital Partners LP 105,137$1,586,5170.30%
Oracle Alpha Inc. 12,500$188,6250.24%
View complete list of ENTRADA THERAPEUTICS INC shareholders